Latest Research in Antifungal resistance and susceptibility

32 research papers · 2026 median publication year

Top Research Topics in Antifungal resistance and susceptibility

Highest-Cited Papers

  1. Associations of psoriasis history with general discrimination‐related experiences in US adults
  2. Patient-Level Cumulative Clinical Benefit of Brodalumab Over 52 Weeks: A Multicentre Real-World Study-IL PSO (Italian Landscape Psoriasis)
  3. Vunakizumab Treatment for Pediatric Generalized Pustular Psoriasis: Two Case Reports
  4. Dose Optimization or Rescue? Interpreting Week 24 Disease Control After Abrocitinib Dose Modification
  5. Economic burden of Generalized Pustular Psoriasis in Malaysia: a multi-centre analysis of indirect costs
  6. Short-term efficacy and safety of guselkumab for moderate-to-severe plaque psoriasis: a systematic review and meta-analysis with a pasi response-depth analysis
  7. Assessment of the Clinical Value of Voriconazole Drug Interactions: A Real-world Disproportionality-Based Analysis
  8. iPROLEPSIS_First report on digital phenotyping for PsA
  9. iPROLEPSIS_First report on digital phenotyping for PsA
  10. Practical Saudi Guidelines on management of moderate-to-severe psoriasis: 2026 update
  11. Real-world Drug Survival of Guselkumab in Patients With Psoriasis Stratified by Weight and Comorbidities: Retrospective, Observational Data From the British Association of Dermatologists Biologics and Immunomodulators Register
  12. Efficacy and Safety of the First Adalimumab Biosimilar in Chinese Children with Severe Plaque Psoriasis: The PISCES Study, a Multicenter Prospective Study
  13. Factors associated with drug adherence in psoriasis: a single‐center, retrospective, questionnaire‐based exploratory study in Bavaria
  14. Insulin resistance in psoriasis: beyond comorbidity?
  15. Abrocitinib monotherapy in refractory atopic dermatitis: A case series
  16. A REVIEW ARTICLE ON AYURVEDIC INSIGHTS INTO GUT HEALTH AND PSORIATIC ARTHRITIS
  17. Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial
  18. 52‐week ivarmacitinib in moderate‐to‐severe atopic dermatitis: A phase 3 trial
  19. IAFA 333 CREAM: AN EVIDENCE-BASED REVIEW OF AYURVEDIC PERSPECTIVES, PHYTOCHEMISTRY AND CLINICAL APPLICATIONS
  20. IAFA 333 CREAM: AN EVIDENCE-BASED REVIEW OF AYURVEDIC PERSPECTIVES, PHYTOCHEMISTRY AND CLINICAL APPLICATIONS
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
L3 Region - - 2026 Sep Q3

Antifungal resistance and susceptibility

32 papers

Top Topics (8)

Psoriasis: Treatment and Pathogenesis20
Dermatology and Skin Diseases4
Spondyloarthritis Studies and Treatments2
Pharmacological Effects of Medicinal Plants2
Antifungal resistance and susceptibility1
Traditional Chinese Medicine Studies1
Dermatological diseases and infestations1
Acne and Rosacea Treatments and Effects1

Top Publications (20)

1.Associations of psoriasis history with general discrimination‐related experiences in US adults2.Patient-Level Cumulative Clinical Benefit of Brodalumab Over 52 Weeks: A Multicentre Real-World Study-IL PSO (Italian Landscape Psoriasis)3.Vunakizumab Treatment for Pediatric Generalized Pustular Psoriasis: Two Case Reports4.Dose Optimization or Rescue? Interpreting Week 24 Disease Control After Abrocitinib Dose Modification5.Economic burden of Generalized Pustular Psoriasis in Malaysia: a multi-centre analysis of indirect costs6.Short-term efficacy and safety of guselkumab for moderate-to-severe plaque psoriasis: a systematic review and meta-analysis with a pasi response-depth analysis7.Assessment of the Clinical Value of Voriconazole Drug Interactions: A Real-world Disproportionality-Based Analysis8.iPROLEPSIS_First report on digital phenotyping for PsA9.iPROLEPSIS_First report on digital phenotyping for PsA10.Practical Saudi Guidelines on management of moderate-to-severe psoriasis: 2026 update11.Real-world Drug Survival of Guselkumab in Patients With Psoriasis Stratified by Weight and Comorbidities: Retrospective, Observational Data From the British Association of Dermatologists Biologics and Immunomodulators Register12.Efficacy and Safety of the First Adalimumab Biosimilar in Chinese Children with Severe Plaque Psoriasis: The PISCES Study, a Multicenter Prospective Study13.Factors associated with drug adherence in psoriasis: a single‐center, retrospective, questionnaire‐based exploratory study in Bavaria14.Insulin resistance in psoriasis: beyond comorbidity?15.Abrocitinib monotherapy in refractory atopic dermatitis: A case series16.A REVIEW ARTICLE ON AYURVEDIC INSIGHTS INTO GUT HEALTH AND PSORIATIC ARTHRITIS17.Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial18.52‐week ivarmacitinib in moderate‐to‐severe atopic dermatitis: A phase 3 trial19.IAFA 333 CREAM: AN EVIDENCE-BASED REVIEW OF AYURVEDIC PERSPECTIVES, PHYTOCHEMISTRY AND CLINICAL APPLICATIONS20.IAFA 333 CREAM: AN EVIDENCE-BASED REVIEW OF AYURVEDIC PERSPECTIVES, PHYTOCHEMISTRY AND CLINICAL APPLICATIONS
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.